Recent Finacing
Recent Raise
Emmaus Life Sciences develops and commercializes therapies for rare diseases, markets Endari (L‑glutamine) for sickle cell disease, conducts Phase 3 trials and autologous tissue‑engineering research.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Emmaus Medical.
